Form 4: ClearPoint Neuro CFO Danilo D'Alessandro Reports Stock Transactions

ClearPoint Neuro's CFO, Danilo D'Alessandro, reports the acquisition and disposal of company stock, including the settlement of restricted stock units for tax obligations.

Summary

• On March 6, 2024, Danilo D'Alessandro, CFO of ClearPoint Neuro, Inc., engaged in transactions involving the company's common stock.
• D'Alessandro acquired 9,383 shares of common stock through the exercise of restricted stock units (RSUs).
• Simultaneously, D'Alessandro disposed of 4,718 shares to cover tax withholding obligations related to the vesting of the RSUs, at a price of $6.24 per share.
• Following these transactions, D'Alessandro beneficially owns 53,594 shares of ClearPoint Neuro common stock.
• The transactions were reported on Form 4, filed with the SEC on March 8, 2024.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into management's holdings and trading activity.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates